Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Finance Watch: Pandion's $55m Series A Funds Localized Bispecifics For Autoimmune Diseases

Jan 23 2018

• By Mandy Jackson

Finance Watch

Related Content

FDA Approval Round Up: Keytruda, Opdivo Add Claims

Sep 25 2017

EU Filings For Amgen/UCB’s Evenity, iv Relenza From GSK, And A New PRIME Product

Jan 09 2018

Pipeline Watch: Topline Phase III Results For Tenapanor, Abemaciclib

Oct 13 2017

Deal Watch: Gilead Ups Its Investment In CAR-T With Cell Design Buy

Dec 07 2017

US IPOs In Review: Relatively Muted Market In 2016 To Continue In 2017

Dec 31 2016

Deal Watch: Seattle Genetics Adds To Antibody-Drug Conjugate Portfolio

Feb 14 2017

Argos And Agenus Trials Pile On Fresh Cancer Vaccine Disappointments

Feb 23 2017

Finance Watch: Genocea, Mateon Shift Strategies, Cut Jobs To Preserve Cash

Sep 28 2017

VC Roundup: Infectious Disease Startup Snags $150m And Former Biogen CEO Scangos

Jan 08 2017

Pherecydes Pharma SA

Feb 27 2012

Deal Watch: Seattle Genetics' Controversial Collaboration With Immunomedics Topples

May 05 2017

Arrowhead Misfires: Abandons Clinical Programs, But Keeps Amgen Deal

Dec 01 2016

Paratek Sees Broad Potential For Omadacycline After Second Phase III Win

Apr 04 2017

Celgene Eyes IO Growth With BeiGene China Pact

Jul 06 2017

Celgene, Agios Ready For Enasidenib Launch After Early Approval

Aug 01 2017

Immuno-Oncology: Sneak Peek Of Preclinical Candidates Waiting In The Wings

Jul 13 2016

Recent Financings Of Private Companies, October 2014

Oct 08 2014

IPOs In Review: Biopharma Offerings Bounced Back In 2017 As Returns Rose

Jan 04 2018

J.P. Morgan Notebook Day 4: CRISPR's Not Worried; Theratechnologies' HIV Niche; And Is Moderna's IPO Coming Soon?

Jan 12 2018

Finance Watch: Mysterious Gossamer Raises $100m As VC Deals Surge Ahead of J.P. Morgan

Jan 06 2018

Interview: Beigene Bursts Onto World IO Scene With Celgene Onboard (Part 2)

Jul 19 2017

Interview: Beigene Bursts Onto World IO Scene With Celgene Onboard

Jul 13 2017

Spark's Luxturna Approval Ushers In A New Gene Therapy Era

Dec 19 2017

Related Companies

Pandion Therapeutics, Inc.

Pfizer Inc.

MedImmune LLC

Biogen, Inc.

Amgen, Inc.

Roche Holding AG

GSK plc

Intarcia Therapeutics, Inc.

Carmot Therapeutics Inc.

Genentech, Inc.

Amgen, Inc.

Pherecydes Pharma SA

BeOne Medicines Ltd.

Bristol Myers Squibb Company

Agios Pharmaceuticals, Inc.

AveXis, Inc.

Spark Therapeutics, Inc.

UroGen Pharma, Ltd.

Genocea Biosciences, Inc.

Arrowhead Pharmaceuticals, Inc.

Paratek Pharmaceuticals, Inc.

Alder Biopharmaceuticals, Inc.

Seagen Inc.

ChemoCentryx, Inc.

OptiNose, Inc.

Additional Topics

Financing StartUps and SMEs Business Strategies Commercial BioPharmaceutical

More from Financing

More from Business

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window